The strong life science actors in Norway joined forces during the conference Nordic Life Science Days 2018.
Oslo Cancer Cluster aims to enhance the visibility of oncology innovation made in Norway by being a significant partner for international clusters, global biopharma companies and academic centres. We used the conference Nordic Life Science Days 2018 in Stockholm this September week to show the growing Norwegian life science environment.
The Norwegian stand
From 2015 onward, we have had a Norwegian stand promoting Norwegian healthcare and life science industry together with other life science actors in Norway. Our partners this year were Norway Health Tech, Aleap, University of Oslo: Life Science, The Life Science Cluster, Invent2, NORIN, Nansen Neuroscience Network, LMI, Innovation Norway and The Norwegian Research Council. Together we represent the essence of Norwegian Life Science.
A European meeting place
There are several important meeting places for life science actors in Europe, such as BIO-Europe, BIO-Europe Spring and Nordic Life Science Days at the top of the list. Oslo Cancer Cluster is the oncology partner at the Nordic Life Science Days.
Are you interested in what the big oncology session during the Nordic Life Science Days 2018 was all about? The topic was cancer immunotherapy, also known as immuno-oncology.
This article gives you the highlights of the session.
More Nordic collaboration
As a region, the Nordic countries are of international importance in the field of cancer research and innovation, especially in precision medicine, and Oslo Cancer Cluster participates in advancing Nordic collaboration. Oslo Cancer Cluster also engages in more cancer specific European events. One example is the Association for Cancer Immunotherapy Meeting (CIMT), which is the largest European meeting in the field of cancer immunotherapy.